KELLI ARTHUR: Open Payments
NPI 1508284522 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 68 payments from 27 companies in 2025. Trend: 2023 $39 · 2024 $0 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $237 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $56 |
| Astellas Pharma US Inc | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Ardelyx, Inc. | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| PFIZER INC. | 2 | $40 |
Products named: AIRSUPRA, UBRELVY, REXULTI, CAPLYTA, VRAYLAR, Auvelity, JARDIANCE, Veozah.
Industry payments across IN — which companies pay providers there.
